NM_000719.7:c.1419C>T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_000719.7(CACNA1C):​c.1419C>T​(p.Ser473Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000225 in 1,606,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.85

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 12-2549971-C-T is Benign according to our data. Variant chr12-2549971-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 263744.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.85 with no splicing effect.
BS2
High AC in GnomAd4 at 24 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.1509C>T p.Ser503Ser synonymous_variant Exon 10 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.1584C>T p.Ser528Ser synonymous_variant Exon 11 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.1509C>T p.Ser503Ser synonymous_variant Exon 10 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.1509C>T p.Ser503Ser synonymous_variant Exon 10 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.1509C>T p.Ser503Ser synonymous_variant Exon 10 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.1509C>T p.Ser503Ser synonymous_variant Exon 10 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.1494C>T p.Ser498Ser synonymous_variant Exon 11 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.1494C>T p.Ser498Ser synonymous_variant Exon 11 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.1410C>T p.Ser470Ser synonymous_variant Exon 10 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.1419C>T p.Ser473Ser synonymous_variant Exon 10 of 46 ENSP00000507309.1
CACNA1CENST00000480911.6 linkn.*26C>T non_coding_transcript_exon_variant Exon 8 of 27 5 ENSP00000437936.2
CACNA1CENST00000480911.6 linkn.*26C>T 3_prime_UTR_variant Exon 8 of 27 5 ENSP00000437936.2

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
152180
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000182
AC:
43
AN:
236824
AF XY:
0.000187
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000299
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000447
Gnomad NFE exome
AF:
0.000289
Gnomad OTH exome
AF:
0.000345
GnomAD4 exome
AF:
0.000232
AC:
337
AN:
1454758
Hom.:
0
Cov.:
31
AF XY:
0.000228
AC XY:
165
AN XY:
722810
show subpopulations
African (AFR)
AF:
0.0000899
AC:
3
AN:
33364
American (AMR)
AF:
0.00
AC:
0
AN:
43896
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26018
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39418
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84456
European-Finnish (FIN)
AF:
0.000397
AC:
21
AN:
52914
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5754
European-Non Finnish (NFE)
AF:
0.000277
AC:
307
AN:
1108786
Other (OTH)
AF:
0.0000997
AC:
6
AN:
60152
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000158
AC:
24
AN:
152180
Hom.:
0
Cov.:
32
AF XY:
0.000135
AC XY:
10
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41440
American (AMR)
AF:
0.000131
AC:
2
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000147
Hom.:
0
Bravo
AF:
0.000102

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 16, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1C: BP4, BP7 -

not specified Benign:1
Oct 30, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CACNA1C-related disorder Benign:1
Feb 23, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Long QT syndrome Benign:1
Sep 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 27, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
5.9
DANN
Benign
0.87
PhyloP100
-1.9
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368065584; hg19: chr12-2659137; API